Targeting ROR1 in combination with pemetrexed in malignant mesothelioma cells.
Miyake N, Ochi N, Yamane H, Fukazawa T, Ikeda T, Yokota E, Takeyama M, Nakagawa N, Nakanishi H, Kohara H, Nagasaki Y, Kawahara T, Ichiyama N, Yamatsuji T, Naomoto Y, Takigawa N.
Miyake N, et al. Among authors: kawahara t.
Lung Cancer. 2020 Jan;139:170-178. doi: 10.1016/j.lungcan.2019.10.024. Epub 2019 Nov 2.
Lung Cancer. 2020.
PMID: 31809978